| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 21,595 | 21,745 | 22:44 | |
| 21,550 | 21,770 | 22:01 |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14:45 | Moderna: Neues zur Tumor-Therapie mRNA-2808 | Moderna hat den ersten Patient in einer klinischen Phase-1/2-Studie mit dem Wirkstoffkandidaten mRNA-2808 behandelt. Der mRNA-basierte T-Cell-Engager wird nach Angaben des US-Biotechunternehmens vom... ► Artikel lesen | |
| 13:02 | Moderna, Inc.: Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma | CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the Company's investigational... ► Artikel lesen | |
| Fr | Watch Cigna, Moderna, Reddit, and More | ||
| Do | S&P 500 Gains and Losses Today: Meta Stock Drops After Earnings; Moderna Surges | ||
| Do | Moderna stock soars after report of potential buyout talks |
